CDSCO Strategy & Documentation Support
Support for India medical-device pathway questions, Medical Device Rules, 2017 documentation readiness, and biocompatibility evidence planning, especially when the India file also needs to stay aligned with FDA, EU MDR, customer, or export-market review.
Key service strengths
Pathway Assessment
Focused support on classification logic, route-to-market questions, and India-specific planning under MDR 2017.
Documentation Readiness
Review of technical and biocompatibility documentation for likely gaps before formal India submission work moves forward.
Biocompatibility Support
Support on applicable IS/ISO 10993 expectations and evidence framing where biological evaluation is part of the India strategy.
Cross-Market Planning
Useful when the India strategy needs to stay aligned with parallel EU MDR or FDA documentation work.
For teams that need India pathway clarity before submission, testing, or export planning
This service fits manufacturers, importers, startups, and regulatory teams that need a clearer India plan before they commission testing, adapt a global file, respond to documentation gaps, or prepare a submission-facing evidence package.
Classification and Pathway Questions
You need a clearer view of the likely regulatory route, applicant structure, or documentation path before more work is commissioned.
Documentation Readiness Check
You already have technical or biocompatibility material and want to understand whether it is strong enough for an India submission strategy.
India + FDA / EU Coordination
You want the India plan to stay coherent with ongoing EU MDR or FDA work rather than creating disconnected documentation streams.
India Evidence Planning
You need the India-facing documentation to connect device classification, intended use, material evidence, biological evaluation, and submission timing.
What can be included in a CDSCO-related support scope
A CDSCO-related project can focus on the practical questions that usually slow teams down: pathway logic, technical-documentation readiness, ISO 10993 evidence, and cross-market consistency.
Classification and Route Review
Initial assessment of device category, likely route, and planning questions under the India medical device framework.
Technical Documentation Readiness
Review of whether the current file set is strong enough for India planning or whether obvious India-specific gaps need to be addressed first.
Biocompatibility Documentation Support
Support on applicable IS/ISO 10993-aligned evidence framing where biological evaluation is relevant to the device and submission path.
Cross-Market Alignment
Useful where one documentation strategy needs to stay coherent across India, EU MDR, and FDA workstreams.
Gap Analysis Before Filing Work
Helps teams decide whether the current file needs minor adaptation, a focused update, or a more substantial documentation remediation plan.
Submission-Readiness Roadmap
A practical next-step map showing which documents, inputs, and decisions should be prepared before formal submission activity continues.
Simple scoping first, then a practical next-step plan
The first step is to understand the device, the current file status, and the India decision you are trying to make. From there, the work can be scoped as a pathway review, documentation-readiness check, biocompatibility evidence plan, or cross-market alignment review.
Describe the Device and Goal
Share the device type, intended use, materials, target route, and whether India is a primary or secondary market in the broader plan.
Assess the Current File
Decide whether the need is pathway planning, documentation readiness, biocompatibility support, or a formal filing question that should be handled separately.
Prioritize the Evidence
Identify the documents, test evidence, risk-file links, and ISO 10993 decisions that should be corrected or clarified first.
Move Into a Defined Scope
The work moves forward with clear deliverables, responsibilities, timelines, and boundaries, so the India file does not drift away from the broader regulatory strategy.
Common questions before starting a CDSCO-related scope
Are you affiliated with or endorsed by CDSCO?
MedDev Advisory provides independent consulting support and is not affiliated with, endorsed by, or approved by CDSCO or the Government of India.
Does this mean you act as an authorized agent?
This page covers independent advisory and documentation support. If a project requires applicant, agent, testing, or formal submission roles, those responsibilities should be defined separately.
Can you support biocompatibility-related documentation for India?
Yes, where the project requires documentation planning tied to applicable IS/ISO 10993 expectations and broader device-safety support.
When should we start this review?
Start before major testing spend, submission preparation, import planning, or cross-market reuse of a file. Early review is usually easier than repairing disconnected evidence later.
Prepare the India file before testing, submission, or cross-market reuse creates rework.
Send the device type, intended use, current documentation status, and whether India is the primary route or part of a broader global strategy. I can help identify what to confirm first and what should become the next defined scope.